Contents
Current Molecular Imaging (Discontinued), Volume 2 - Number 2
Molecular Markers of Glioblastoma and the Potential for Integration with Imaging: the Future for Assigning Prognosis and Best Treatment Strategy
, 2(2): 107 - 116Noelyn A. Hung, Janice A. Royds and Tania L. Slatter
DOI: 10.2174/2211555211302020001
Evaluation of Tophaceous Gout by FDG-PET/CT and Bone Scan
, 2(2): 117 - 119Gottfried Wimmer, Simon W. Stoecklegger, Tatjana Stojakovic, Josef F. Hofer and Robert Pichler
DOI: 10.2174/2211555211302020002
Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer
, 2(2): 120 - 129Zahra Heidari, Mojtaba Salouti and Reyhaneh Sariri
DOI: 10.2174/2211555211302020003
The Neurotachykinin NK1 Receptor – A Novel Target for Diagnostics and Therapy
, 2(2): 130 - 147Susanne Nikolaus, Maria Angelica de Souza Silva, Hubertus Hautzel and Hans-Wilhelm Muller
DOI: 10.2174/2211555211302020004
Fabrication of Split-Luciferase Complementation Assays for Molecular Imaging
, 2(2): 148 - 157Sung Bae Kim and Takeaki Ozawa
DOI: 10.2174/22115552113029990001
Local Recurrence vs Radiotherapy-Induced Edema in Advanced Laryngeal Carcinoma: Is FDG PET/CT Up to the Challenge?
, 2(2): 158 - 163Sagi Tshori, Martine Klein, Jeffrey Weinberger, Roland Chisin and Nanette Freedman
DOI: 10.2174/22115552113029990010
In Vivo Monitoring of Cell Based Therapy in the Liver
, 2(2): 164 - 176Ashwini Ketkar-Atre and Uwe Himmelreich
DOI: 10.2174/22115552113029990011
Biological Applications of ZnO Nanoparticles
, 2(2): 177 - 192Hua-Juan Zhang and Huan-Ming Xiong
DOI: 10.2174/22115552113029990012
Webmaster Contact: info@benthamscience.net